STGD1 clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Tinlarebant in Subjects With Stargardt Disease

    open to eligible people ages 12-20

    The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of tinlarebant in subjects with Stargardt Disease

    at UCSD UCSF

Last updated: